Doctor of Philosophy in Medical Genetics (PhD)


The UBC Department of Medical Genetics is an inspiring and productive community of scholars of genetics and genomics. It is an outstanding provider of knowledge, technical expertise, and compassionate care for our patients. Faculty members in the Department of Medical Genetics are at the forefront of their fields using cutting edge genetic, epigenetic, genomic, and bioinformatic methodologies to gain insight into diseases such as cancer, diabetes, obesity, neurodegenerative and neurological disorders, and other genetic diseases. Research is highly interactive and often involves local, national, and international collaborations which further enrich the research experience.

Individual labs conduct clinical and/or translational research and basic experimental research engaging a wide variety of approaches including the use of model organisms such as mice, flies (D. melanogaster), worms (C. elegans), and yeast (S. cerevisiae).

What makes the program unique?

The mission of the Department of Medical Genetics is to pursue basic and clinical research for diagnosis, prevention and treatment of genetic disease. Our goal is to be a world leader in the research, clinical practice and teaching of Genetic Medicine.

Quick Facts

Doctor of Philosophy
Life Sciences
Mode of delivery
On campus
Registration options
Medical Genetics
Program Components
Faculty of Medicine

Program Enquiries

If you have reviewed the information on this program page and understand the requirements for this program, you may send an enquiry

Research Information

Research Focus

Research in the Department of Medical Genetics covers the study of human genetics with areas of focus in mammalian development, regulation of gene expression, genetic diseases due to single gene or complex inheritance, birth defects, reproduction, cancer, immunology, genomics, bioinformatics, ethics and population health.

Research in the Department of Medical Genetics covers the study of human genetics with areas of focus in mammalian development, regulation of gene expression, genetic diseases due to single gene or complex inheritance, birth defects, reproduction, cancer, immunology, genomics, bioinformatics, ethics and population health.

Research Areas of Expertise:
• Cancer Genetics & Genomics
• Clinical Genetics, Genetic Counselling, Ethics & Policy
• Developmental Genetics & Birth Defects
• DNA Repair & Genome Stability
• Epigenetics, Epigenomics & Gene Regulation
• Genetic Epidemiology & Population Genetics
• Genomics & Bioinformatics
• Immunogenetics
• Neuroscience & Neurodegenerative Disease Genetics
• Pharmacogenomics
• Proteomics
• Stem Cells & Gene Therapy

Program Components

Medical Genetics Rotation Program: MSc and PhD applicants who have applied for the September-start, and who are highest ranked by the Medical Genetics Admissions Committee, will be offered the opportunity to join the Medical Genetics Rotation Program. The four top-ranked applicants offered these positions will also receive one-year Rotation Program Awards. Rotation Program students rotate through three different laboratories before choosing a final, thesis lab. Rotations are for nine-weeks each, from September to April. The Rotation Program is open to Canadians, Permanent Residents of Canada, and international applicants.

Research Facilities

Medical Genetics graduate student training takes place at multiple state-of-the-art facilities, representing a diverse collection of training environments. These include several centres on the UBC Point Grey Campus (e.g. Life Sciences Centre, Brain Research Centre, Michael Smith Laboratories) and health authority research centres (e.g Michael Smith Genome Sciences Centre, BC Children’s Hospital Research Institute, Vancouver Coastal Health Research Institute, and Terry Fox Laboratory at the BC Cancer Agency). Available research services and facilities include: animal modeling, biobanking, bioanalyzer, bioinformatics, DNA sequencing, flow cytometry, genotyping and gene expression, histology and imaging, transgenic facility, support to perform biostatistics, clinical trials, data management and access to health research and evaluation services.

Application Notes

SEPTEMBER-START APPLICANTS: MSc and PhD applicants who are ranked by the Medical Genetics Admissions Committee as 'admissible' must secure a supervisor commitment prior to receiving an admissions offer from UBC. Deadline for supervisor commitment is June 1st.
JANUARY-START APPLICANTS: There is no January-start available to MSc applicants. PhD applicants who have completed a MSc degree and meet all of the prerequisite requirements may apply to the January-start. Deadline for supervisor commitment is July 1st.


Document Requirements

OFFICIAL transcripts and degree certificates. You MUST include a grading key / legend. (Unofficial / web transcripts; and poor-quality scans of transcripts are NOT acceptable.)

Three letters of references.

Personal letter of intent and a curriculum vitae.


TOEFL (ibT) Overall Score Requirement


IELTS Overall Score Requirement


Supervisor commitment required prior to application?


GRE required?

Not required

Prerequisites / Course Requirements

Upper-level / advanced genetics, genomics, genetic engineering, biochemistry, molecular biology and biostatistics (statistics). Bioinformatics is strongly recommended but not required.
Note: Medical doctors (MBBS) generally do not meet the academic or research requirements of this Program.

Other Requirements

Applicants must have worked in a relevant laboratory setting and acquired research experience and skills.
Excellent references that assess the applicant's research expertise, accomplishments and aptitude.
Grade Point Average (GPA) – international degrees: Check your COUNTRY of education ( for minimum GPA and length of degree program to determine if your credentials meet UBC admission requirements. Admission GPA is based on the final, overall standing (grade) achieved in your last completed degree.
GPA calculation of Canadian degree programs is based on all upper level courses taken in the most recent, full time degree.

Deadline Details

Application Deadline

Deadline to submit online application. No changes can be made to the application after submission.

Transcript Deadline

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Referee Deadline

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

September 2020 Intake

Application Open Date
01 December 2019
Canadian Applicants
Application Deadline: 01 February 2020
Transcript Deadline: 01 February 2020
Referee Deadline: 14 February 2020
International Applicants
Application Deadline: 01 February 2020
Transcript Deadline: 01 February 2020
Referee Deadline: 14 February 2020

January 2021 Intake

Application Open Date
15 March 2020
Canadian Applicants
Application Deadline: 15 April 2020
Transcript Deadline: 15 April 2020
Referee Deadline: 30 April 2020
International Applicants
Application Deadline: 15 April 2020
Transcript Deadline: 15 April 2020
Referee Deadline: 30 April 2020

September 2021 Intake

Application Open Date
01 December 2020
Canadian Applicants
Application Deadline: 01 February 2021
Transcript Deadline: 01 February 2021
Referee Deadline: 14 February 2021
International Applicants
Application Deadline: 01 February 2021
Transcript Deadline: 01 February 2021
Referee Deadline: 14 February 2021

Funding Sources

All students accepted to the Medical Genetics Graduate Program receive a minimum yearly stipend.  This applies to both MSc and PhD, Canadian and international students.

Stipend Amount and Duration:

The recommended minimum yearly stipend for a full time Medical Genetics (MEDG) thesis-based graduate student is as follows:

MSc and PhD (pre-advancement to candidacy): $24,300
PhD (post-advancement to candidacy): $27,000

The student pays tuition from their stipend (the cost of tuition depends on whether the student is domestic or international as well as on the time spent in our graduate program). The stipend may come from an independent studentship award and/or from the Research Supervisor's research grant. Admission to the Medical Genetics Graduate Program normally includes a commitment from the Supervisor to ensure that each student is supported to the recommended funding level.  Exceptions to this policy may be granted under unusual circumstances. Financial support from personal resources is not acceptable as “funding” for incoming students in the Medical Genetics Graduate Program.

The duration of the annual stipend is normally two years for an MSc student and four years for a PhD student. After the two-year MSc and four-year PhD point, continued funding is at the discretion of the Supervisor.  The Supervisor should inform their student in writing (with a copy to the Medical Genetics Graduate Program office) at least six months prior to the end-date of the student's stipend.

Funding depends both on satisfactory academic and research progress, as determined by the Student’s Supervisory Committee, and on the Research Supervisor's continued grant support.  Termination of funding for other justifiable reasons must be approved by a majority of the Medical Genetics Graduate Advisory Committee.

Career Outcomes

53 students graduated between 2005 and 2013: 1 is in a non-salaried situation; for 4 we have no data (based on research conducted between Feb-May 2016). For the remaining 48 graduates:

RI (Research-Intensive) Faculty: typically tenure-track faculty positions (equivalent of the North American Assistant Professor, Associate Professor, and Professor positions) in PhD-granting institutions
TI (Teaching-Intensive) Faculty: typically full-time faculty positions in colleges or in institutions not granting PhDs, and teaching faculty at PhD-granting institutions
Term Faculty: faculty in term appointments (e.g. sessional lecturers, visiting assistant professors, etc.)
Sample Employers in Higher Education
University of British Columbia (9)
Stanford University (2)
University of Toronto (2)
Washington University in St Louis (2)
Babraham Institute
University of Hong Kong
University of Calgary
Duke University
Ulm University
University of Warwick
Sample Employers Outside Higher Education
BC Cancer Agency (3)
Hospital for Sick Children (2)
Mayo Clinic
PROOF Centre of Excellence
InSilixa, Inc.
Vancouver Coastal Health
Rick Hansen Institute
Fred Hutchinson Cancer Research Center
Provincial Health Services Authority
Spectrum Mobile Health
Sample Job Titles Outside Higher Education
Postdoctoral Fellow (3)
Scientist (2)
Research Associate (2)
Site Manager
Staff Scientist
Strategic Development Officer
Management Consultant
Director, Co-founder
Associate Project Manager
Senior Product Marketing Manager
PhD Career Outcome Survey
You may view the full report on career outcomes of UBC PhD graduates on
These data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.
Career Options

The PhD program in Medical Genetics is a research-based, thesis-based program which generally takes five to six years to complete. Graduates find employment in the public and private sector, and also pursue further studies in the field of Medical Genetics. Following is a brief sample of occupations that our graduates are pursuing:

  • Academia:
    • Assistant Professor / Associate Clinical Professor, etc.
    • Principal Investigator
    • Canada Research Chair
  • Advanced Training:
    • Post-doctoral Fellow
    • Laboratory Genetics and Genomics Postdoctoral Fellow
    • Fellow of the Canadian College of Medical Genetics
    • Postdoctoral Clinical Laboratory Fellow
    • Diagnostics Laboratory Manager
    • Medical Doctor
  • Industry / Clinical Careers:
    • Clinical Molecular Geneticist and Cytogeneticist
    • Research Program Manager
    • Online Marketing Coordinator
    • Scientific Sales Representative
    • Research and Development Scientist

Alumni on Success

Ryan Yuen

Job Title
The Hospital for Sick Children

Jane Gair

Job Title
Teaching Professor/ Affiliate Professor of Teaching
University of Victoria/ University of British Columbia

Steven Maltby

Job Title
Research Academic
Hunter Medical Research Institute & The University of Newcastle

Obi Griffith

Job Title
Assistant Professor
Washington University School of Medicine

Tuition / Program Costs

FeesCanadian Citizen / Permanent Resident / Refugee / DiplomatInternational
Application Fee$104.00$168.25
Tuition *
Installments per year33
Tuition per installment$1,665.26$2,925.58
Tuition per year
(plus annual increase, usually 2%-5%)
Int. Tuition Award (ITA) per year (if eligible) $3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)$930.14 (approx.)
Costs of living (yearly)starting at $16,884.10 (check cost calculator)
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Statistical Data

Enrolment Data

New registrations24414
Total enrolment4237373941

Completion Rates & Times

This program has a graduation rate of 100% based on 10 students admitted between 2006 - 2009. Based on 9 graduations between 2015 - 2018 the minimum time to completion is 4.00 years and the maximum time is 8.33 years with an average of 5.92 years of study. All calculations exclude leave times.
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 22 March 2019]. Enrolment data are based on March 1 snapshots. Program completion data are only provided for datasets comprised of more than 4 individuals. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs [data updated: 27 October 2019].

Research Supervisors

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

  • Aparicio, Samuel (Breast cancer, genome sequencing )
  • Arbour, Laura (northern and aboriginal health issues as they pertain to genetics)
  • Austin, Jehannine (Genetics, genomics, genetic counseling, psychiatric illness, mental illness, mental health, psychiatry, schizophrenia, bipolar disorder, depression, postpartum depression, perinatal mental health, Mood & Anxiety Disorders, Schizophrenia)
  • Birol, Inanc (bioinformatics, computational biology, genomics, transcriptome analysis, next generation sequencing, cancer, Bioinformatics, sequence assembly, transcriptomics, gene regulation networks, high throughput informatics for big data)
  • Brinkman, Ryan (Bioinformatics, flow cytometry, high throughput data analysis, data standars, GvHD biomarker identification, cluster identification)
  • Brooks-Wilson, Angela (human genetics, cancer genetics, cancer families, longevity, Super seniors, genetic susceptibility)
  • Brown, Carolyn Janet (Gene Regulation and Expression, Chromosomes: Structure / Organization, Applied Genetics, Chromosomes: Structure / Organization, Epigenetic control of gene expression, X-chromosome inactivation, Long non-coding RNAs, XIST RNA, Genes escaping X-chromosome inactivation, DNA methylation)
  • Burgess, Michael (Genetics and Ethics, Ethics and Health, Applied Ethics, Individual and Collective Ethics, Participatory research, Public deliberation, Health Policy, Science Policy, Deliberative Democracy)
  • Carleton, Bruce (Pharmacogenomics, Adverse drug reactions (ADRs), Drug safety and effectiveness, Clinical pharmacology, Pharmacovigilance)
  • Clarke, Lorne (Lysosomal storage disease, disorders or sulfate transport, mucopolysaccharidosis, phenylketonuria)
  • Conibear, Elizabeth (Molecular Genetics, Cell Signaling and Cancer, Genomics and Proteomics, Neurodegenerative Diseases, Membranes, Enzymes and Proteins, Parkinson's Disease, Protein Palmitoylation, Vesicle Trafficking)
  • Eaves, Constance Jean (Normal and leukemic stem cells, normal and malignant breast stem cells)
  • Friedman, Jan Marshall (Genetics and Heredity, Developmental Genetics, Genomics, Application of whole genome sequencing to diagnose genetic disease, Clinical genomics, Neurofibromatosis, Birth defects epidemiology)
  • Gibson, William (Genetic Diseases, Chromosomes: Structure / Organization, Epigenetics)
  • Goldowitz, Daniel (Genetic basis of brain disease, neurobiology of autism, Huntingtong's gene, mouse/mice epigenetics, gene regulatory network)
  • Hayden, Michael (Genetic Diseases, Neurodegenerative Diseases, Huntington disease, Disease progression, Diabetes, Neurodegenerative disorders, Gene therapy, Drug development)
  • Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
  • Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
  • Hoodless, Pamela (Embryonic Development, Genomics, Heart Valve / Valvular Diseases, Liver, Stem Cells and Organogenesis, Developmental Genetics, Embryology, Transcriptional regulation, Epigenetics, Heart valve formation, Liver development)
  • Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
  • Jefferies, Wilfred Arthur (Iron transport molecules)
  • Jiang, Xiaoyan (Cancer Genetics, Cell Signaling and Cancer, Leukemia, Cancer Diagnosis and Detection, Cell Therapy of Cancer, Immunotherapy, Basic and translational leukemia research, Leukemic stem cell biology , Gene regulation , Drug resistance , Proteomics, Immunotherapy)
  • Jones, Steven J (Bioinformatics, genome science, mutations, cancer progression)
  • Kobor, Michael (Epigenetics, Social Epigenetics, Molecular Biology , Chromatin Biology)


Recent Doctoral Citations

  • Dr. Chaahat S.B. Singh
    "Dr. Singh studied cerebral vessel growth in Alzheimer's disease. She repurposed drugs used in cancer therapy to reduce pathogenic blood vessel formation and improve cognition in mouse models of Alzheimer's. Findings from these studies improve our understanding of how an altered blood vessel growth can contribute to pathogenesis of Alzheimer disease." (May 2019)
  • Dr. Sumaiya Islam
    "Dr. Islam examined how DNA is chemically modified in neurological diseases including Huntington's disease, brain cancer and alcoholism. Her work highlighted how we can use these DNA marks to understand how genes are regulated in different types of healthy and diseased tissues, and to diagnose and track the progression of neurological disorders." (November 2018)
  • Dr. Lisa M McEwen
    "Dr. McEwen helped characterize an epigenetic process called DNA methylation. She analyzed thousands of genome-wide DNA profiles ranging from newborns to centenarian-aged individuals. Her work increases our understanding of how methylation changes across the life-course and the potential implications it may have on human longevity." (November 2018)
  • Dr. Jack Hickmott
    "Dr. Hickmott worked towards the development of new gene-based therapies for the rare genetic blindness known as aniridia. He developed new DNA elements to direct the expression of new therapies, further characterized a mouse model of aniridia, and used that mouse to show that PAX6 gene therapy can, at least, temporarily improve the aniridic cornea." (November 2018)
  • Dr. Samantha Lea Wilson
    "Dr. Wilson studied modifications made to DNA in placentas to identify which pregnancies were at risk for complications such as preeclampsia and intrauterine growth restriction. She found that changes in the placental DNA could be used to classify some complications or used to identify new protein biomarkers in maternal blood during pregnancy." (May 2018)

Further Program Information


September 2020 Intake

Application Open Date
01 December 2019
Canadian Applicant Deadline
01 February 2020
International Applicant Deadline
01 February 2020

January 2021 Intake

Application Open Date
15 March 2020
Canadian Applicant Deadline
15 April 2020
International Applicant Deadline
15 April 2020

September 2021 Intake

Application Open Date
01 December 2020
Canadian Applicant Deadline
01 February 2021
International Applicant Deadline
01 February 2021

Supervisor Search


Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update the application inquiries contact details please use this form.